Nanotechnology in Cancer Treatment: Technologies and Global Markets
商品番号 : SMB-76757
| 出版社 | BCC Research |
| 出版年月 | 2025年4月 |
| ページ数 | 107 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 2,950 |
| 種別 | 英文調査報告書 |
Report Highlights
The report provides an analysis of the global market for nanotechnology in cancer treatment. Using 2023 as the base year, the report provides estimated market data for 2024 through 2029. The market in this report is segmented into product type, cancer type, and region. The report concludes with profiles of the major players in the market.
本レポートは、がん治療におけるナノテクノロジーの世界市場を分析しています。2023年を基準年として、2024年から2029年までの市場予測データを提供しています。本レポートでは、市場を製品タイプ、がんの種類、地域に分類しています。最後に、主要プレーヤーのプロフィールを掲載しています。
Report Scope
This report provides detailed information about nanotechnology in the cancer treatment market. The report analyzes the market trends for nanotechnology in cancer treatment with data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024–2029), and regional markets. This report highlights nanotechnology in cancer treatment’s current and future market potential and analyzes the competitive environment. The report covers regulatory scenarios, drivers, restraints and opportunities. The report also covers market estimates for 2029 and market shares for key players.
The market scope in this report is segmented into product type and cancer types. Based on product type, the market is segmented into liposomes, polymeric nanoparticles, micelles, hydrogels, and dendrimers. The market is segmented by cancer type into lungs, breast, leukemia, lymphoma, melanoma and other cancers.
The market has been segmented into the following regions: North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The regional segment includes a detailed analysis of major countries such as the U.S., Canada, Mexico, Germany, the U.K., Italy, Spain, France, Japan, China, South Korea, Australia and India. For market projections, data will be provided for 2023 as the base year, with forecasts for 2024 through 2029.
The report’s goals include:
– Analyzing product and cancer type.
– Analyzing global market size and segments.
– Reviewing market constraints and drivers.
– Providing detailed market forecasts for 2029.
– Assessing market shares, competitiveness and industry structure.
– Identifying potential long-term impacts on nanotechnology in the cancer treatment market.
Report Synopsis
| Report Metrics | Details | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2023 | ||||||||||
| Forecast period considered | 2024-2029 | ||||||||||
| Base year market size | $102.4 billion | ||||||||||
| Market size forecast | $265.4 billion | ||||||||||
| Growth rate | CAGR of 17.4% for the forecast period of 2024-2029 | ||||||||||
| Units considered | $ Millions | ||||||||||
| Segments covered | Product Type, Cancer Type | ||||||||||
| Regions covered | North America, Europe, Asia-Pacific, South America, Rest of the World | ||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, France, Italy, Spain, U.K., Austria, Sweden, Denmark, Poland, Turkey, Switzerland, the Netherlands, China, Japan, India, South Korea, Australia, Thailand, Singapore, Malaysia, New Zealand, Vietnam, Brazil, Argentina, Colombia, Paraguay, Peru, Middle East and Africa | ||||||||||
| Key Market Drivers |
| ||||||||||
| Companies studied |
|
Report Includes
– Analyses of the trends in global markets for nanotechnology in cancer treatment, with revenue data for 2022 to 2023, estimates for 2024, forecasts for 2025, and projected CAGRs through 2029
– Estimates of the size and revenue prospects for the global market, along with a market share analysis by product type, application and region
– Facts and figures pertaining to the global market dynamics, technological advances, regulations and standards, and the impact of macroeconomic factors
– Insights derived from the Porter’s Five Forces model, as well as global supply chain and PESTLE analyses
– Information pertaining to evolving trends and patterns, recent technological breakthroughs, and the types of nanostructured materials, nanodevices, and nanotools used for research, diagnosis and therapy of the types of cancer
– Statistics regarding the incidence and prevalence of cancer cases, as well as global mortality figures
– Analysis of relevant patents and patent grants
– Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
– Analysis of the industry structure, including companies’ market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
– Profiles of leading companies
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Chapter 2 Market Overview
Overview
Patent Analysis
Analysis of Porter’s Five Forces
Bargaining Power of Buyers
Bargaining Power of Suppliers
Potential for New Entrants
Threat of Substitutes
Competitiveness in the Industry
Future Perspective
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Prevalence of Cancer Cases Globally
Rise in Government Funding and Pharmaceutical R&D Spending
Nanoparticles in Cancer Treatment: Advantages
Precision Targeting of Cancer Cells with Nanomaterials
Market Restraints
Roadblocks to Clinical Nanoparticle Use
Lack of Oncology Professionals
Market Opportunities
Mechanism of Nanoparticles in Overcoming Drug Resistance
Cancer Proteomics
Chapter 4 Regulatory Landscape
Overview
U.S.
Europe
Japan
Chapter 5 Emerging Technologies and New Developments
Emerging Trends and Technologies
Artificial Intelligence
Quantum Dots
Oncology Products Pipeline
Chapter 6 Market Segment Analysis
Segmentation Breakdown
Market Analysis by Product Type
Global Market Size and Forecast
Liposomes
Polymeric Nanoparticles
Micelles
Hydrogels
Dendrimers
Market Analysis by Cancer Type
Global Market Size and Forecast
Lung Cancer
Breast Cancer
Leukemia
Lymphoma
Melanoma
Other Cancers
Geographic Breakdown
Market Analysis by Region
Global Market Size and Forecast
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Overview
Competitive Landscape
Chapter 8 Appendix
Methodology
Abbreviations
Sources
Company Profiles
ASTRAZENECA
BAXTER
BOSTON SCIENTIFIC CORP.
BRISTOL-MYERS SQUIBB CO.
- HOFFMANN-LA ROCHE LTD.
JAZZ PHARMACEUTICALS INC.
LES LABORATOIRES SERVIER
NOVARTIS AG
PFIZER INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
Other Emerging Players
List of Tables
Summary Table : Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 1 : Select Patent Grants on Nanotechnology in Cancer Treatment, 2024 and 2025
Table 2 : Porter’s Five Forces Analysis: Nanotechnology in Cancer Treatment Market
Table 3 : Selected Clinical Trials Studies on Nanotechnology in Cancer Treatment, 2024
Table 4 : Global Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 5 : Global Market for Nanotechnology-based Liposomes in Cancer Treatment, by Region, Through 2029
Table 6 : Global Market for Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, Through 2029
Table 7 : Global Market for Nanotechnology-based Micelles in Cancer Treatment, by Region, Through 2029
Table 8 : Global Market for Nanotechnology-based Hydrogels in Cancer Treatment, by Region, Through 2029
Table 9 : Global Market for Nanotechnology-based Dendrimers in Cancer Treatment, by Region, Through 2029
Table 10 : Global Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 11 : Global Market for Nanotechnology in Lung Cancer Treatment, by Region, Through 2029
Table 12 : Global Market for Nanotechnology in Breast Cancer Treatment, by Region, Through 2029
Table 13 : Global Market for Nanotechnology in Leukemia Cancer Treatment, by Region, Through 2029
Table 14 : Global Market for Nanotechnology in Lymphoma, by Region, Through 2029
Table 15 : Global Market for Nanotechnology in Melanoma Treatment, by Region, Through 2029
Table 16 : Global Market for Nanotechnology in Other Cancers, by Region, Through 2029
Table 17 : Global Market for Nanotechnology in Cancer Treatment, by Region, Through 2029
Table 18 : North American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 19 : North American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 20 : North American Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 21 : European Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 22 : European Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 23 : European Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 24 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 25 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 26 : Asia-Pacific Market for Nanotechnology in Cancer Treatment, by Country, Through 2029
Table 27 : Middle East and African Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 28 : Middle East and African Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 29 : South American Market for Nanotechnology in Cancer Treatment, by Product Type, Through 2029
Table 30 : South American Market for Nanotechnology in Cancer Treatment, by Cancer Type, Through 2029
Table 31 : Major Market Players in Nanotechnology in Cancer Treatment, 2023
Table 32 : Abbreviations Used in this Report
Table 33 : Information Sources in this Report
Table 34 : AstraZeneca: Company Snapshot
Table 35 : AstraZeneca: Financial Performance, FY 2022 and 2023
Table 36 : AstraZeneca: Product Portfolio
Table 37 : AstraZeneca: News/Key Developments, 2023 and 2024
Table 38 : Baxter: Company Snapshot
Table 39 : Baxter: Financial Performance, FY 2022 and 2023
Table 40 : Baxter: Product Portfolio
Table 41 : Baxter: News/Key Developments, 2021
Table 42 : Boston Scientific Corp.: Company Snapshot
Table 43 : Boston Scientific Corp.: Financial Performance, FY 2022 and 2023
Table 44 : Boston Scientific Corp.: Product Portfolio
Table 45 : Boston Scientific Corp.: News/Key Developments, 2021
Table 46 : Bristol-Myers Squibb Co.: Company Snapshot
Table 47 : Bristol-Myers Squibb Co.: Financial Performance, FY 2022 and 2023
Table 48 : Bristol-Myers Squibb Co.: Product Portfolio
Table 49 : F. Hoffmann-La Roche Ltd.: Company Snapshot
Table 50 : F. Hoffmann-La Roche Ltd.: Financial Performance, FY 2022 and 2023
Table 51 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 52 : Jazz Pharmaceuticals Inc.: Company Snapshot
Table 53 : Jazz Pharmaceuticals Inc.: Financial Performance, FY 2022 and 2023
Table 54 : Jazz Pharmaceuticals Inc.: Product Portfolio
Table 55 : Les Laboratoires Servier: Company Snapshot
Table 56 : Les Laboratoires Servier: Financial Performance, FY 2022 and 2023
Table 57 : Les Laboratoires Servier: Product Portfolio
Table 58 : Les Laboratoires Servier: News/Key Developments, 2023 and 2024
Table 59 : Novartis AG: Company Snapshot
Table 60 : Novartis AG: Financial Performance, FY 2022 and 2023
Table 61 : Novartis AG: Product Portfolio
Table 62 : Pfizer Inc.: Company Snapshot
Table 63 : Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 64 : Pfizer Inc.: Product Portfolio
Table 65 : Pfizer Inc.: News/Key Developments, 2023
Table 66 : Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 67 : Teva Pharmaceutical Industries Ltd.: Financial Performance, FY 2022 and 2023
Table 68 : Teva Pharmaceutical Industries Ltd.: Product Portfolio
Table 69 : Few Emerging Players in Nanotechnology in Cancer Treatment Market
List of Figures
Summary Figure : Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 1 : Market Dynamics of Nanotechnology in Cancer Treatment
Figure 2 : Breakdown of Most Frequent Cancers in Women, by Type, 2022
Figure 3 : Breakdown of Most Frequent Cancers in Men, by Type, 2022
Figure 4 : Estimated Cancer Incidence and Mortality Cases Globally, by Cancer Type, 2024
Figure 5 : Trends in NCI Funding for Cancer Research, by Year, 2012–2019
Figure 6 : Global Pharmaceutical R&D Spending, 2020–2026
Figure 7 : Global Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 8 : Global Market Shares of Nanotechnology-based Liposomes in Cancer Treatment, by Region, 2023
Figure 9 : Global Market Shares of Nanotechnology-based Polymeric Nanoparticles in Cancer Treatment, by Region, 2023
Figure 10 : Global Market Shares of Nanotechnology-based Micelles in Cancer Treatment, by Region, 2023
Figure 11 : Global Market Shares of Nanotechnology-based Hydrogels in Cancer Treatment, by Region, 2023
Figure 12 : Global Market Shares of Nanotechnology-based Dendrimers in Cancer Treatment, by Region, 2023
Figure 13 : Global Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 14 : Global Market Shares of Nanotechnology in Lung Cancer Treatment, by Region, 2023
Figure 15 : Global Market Shares of Nanotechnology in Breast Cancer Treatment, by Region, 2023
Figure 16 : Global Market Shares of Nanotechnology in Leukemia Cancer Treatment, by Region, 2023
Figure 17 : Global Market Shares of Nanotechnology in Lymphoma, by Region, 2023
Figure 18 : Global Market Shares of Nanotechnology in Melanoma Treatment, by Region, 2023
Figure 19 : Global Market Shares of Nanotechnology in Other Cancers, by Region, 2023
Figure 20 : Global Market Shares of Nanotechnology in Cancer Treatment, by Region, 2023
Figure 21 : North American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 22 : North American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 23 : North American Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 24 : European Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 25 : European Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 26 : European Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 27 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 28 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 29 : Asia-Pacific Market Shares of Nanotechnology in Cancer Treatment, by Country, 2023
Figure 30 : Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 31 : Middle East and African Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 32 : South American Market Shares of Nanotechnology in Cancer Treatment, by Product Type, 2023
Figure 33 : South American Market Shares of Nanotechnology in Cancer Treatment, by Cancer Type, 2023
Figure 34 : AstraZeneca: Revenue Share, by Business Unit, FY 2023
Figure 35 : AstraZeneca: Revenue Share, by Country/Region, FY 2023
Figure 36 : Baxter: Revenue Share, by Business Unit, FY 2023
Figure 37 : Baxter: Revenue Share, by Country/Region, FY 2023
Figure 38 : Boston Scientific Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39 : Boston Scientific Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40 : Bristol-Myers Squibb Co.: Revenue Share, by Business Unit, FY 2023
Figure 41 : Bristol-Myers Squibb Co.: Revenue Share, by Country/Region, FY 2023
Figure 42 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 43 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 44 : Jazz Pharmaceuticals Inc.: Revenue Share, by Business Unit, FY 2023
Figure 45 : Jazz Pharmaceuticals Inc.: Revenue Share, by Country/Region, FY 2023
Figure 46 : Les Laboratoires Servier: Revenue Share, by Business Unit, FY 2023
Figure 47 : Les Laboratoires Servier: Revenue Share, by Region, FY 2023
Figure 48 : Novartis AG: Revenue Share, by Business Unit, FY 2023
Figure 49 : Novartis AG: Revenue Share, by Country/Region, FY 2023
Figure 50 : Pfizer Inc.: Revenue Share, by Business Unit, FY 2023
Figure 51 : Pfizer Inc.: Revenue Share, by Country/Region, FY 2023
Figure 52 : Teva Pharmaceutical Industries Ltd.: Market Share, by Business Unit, FY 2023
Figure 53 : Teva Pharmaceutical Industries Ltd.: Market Share, by Region, FY 2023
BCC Research（BCCリサーチ）はライフサイエンス、センサ、マテリアル、環境、商取引関連市場を中心とした広範な市場調査レポートを出版する米国の調査会社です。
ライセンス別価格表
2024年11月より価格構成が大幅に変更になりました。最新の価格についてはお問合せください。
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
新価格表
ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 4,650 | USD 5,580 | USD 6,696 | USD 8,035 |
ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,950 | USD 3,540 | USD 4,248 | USD 5,098 |
ライセンスタイプ3
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 2,500 | USD 3,000 | USD 3,600 | USD 4,320 |
旧価格表
旧ライセンスタイプ1
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 5,500 | USD 6,600 | USD7.920 | USD 9,504 |
旧ライセンスタイプ2
| シングルユーザ | 2-5ユーザ | サイト | エンタープライズ |
| USD 3,500 | USD 4,200 | USD 5,040 | USD 6,048 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- 2-5ライセンス
- 同一企業内5名までレポートファイルのご利用が可能です。
- サイトライセンス
- 同一企業同住所内でレポートファイルのご利用が可能です。
- エンタープライズライセンス
- 同一企業内人数無制限でレポートファイルのご利用が可能です。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- ご注文後3営業日以内
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
BCC Researchが出版する調査レポートのサンプルページのご依頼、見積り、ご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 不織布ろ材の世界市場 2025-05-07
- 世界のグリーンスチール市場 2025-05-05
- デジタルパソロジーの技術と世界市場 2025-04-29
- 持続可能エネルギーの調査レビュー 2024年 2025-04-22
- 世界の燃料電池スタック市場 2025-04-22